Experience Fenwick Represents Merck Global Health Innovation Fund in Sale of Preventice Solutions to Boston Scientific January 21, 2021
Experience Fenwick Represents DocuSign in Offering of $690M of 0% Convertible Senior Notes Due 2024 January 15, 2021
Media Coverage Nasdaq Board Diversity Proposal Attracts Support and Suggested Tweaks January 15, 2021